IL10RA and myeloid sarcoma: IL10RA, which appeared to be expressed at lower levels in B cells of MS patients compared to healthy controls as previously reported [77], mediates the immunosuppressive signal of IL10 by inhibiting the expression of pro-inflammatory genes [78].